NCT00490802View on ClinicalTrials.gov

Intranasal Oxytocin in the Treatment of Autism

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

September 30, 2011

Study Completion Date

April 30, 2012

Conditions
Autism
Interventions
DRUG

Oxytocin

Intranasal Oxytocin

DRUG

Placebo

Placebo Comparator

Trial Locations (1)

10029-6574

Mount Sinai School of Medicine, New York

All Listed Sponsors
collaborator

Icahn School of Medicine at Mount Sinai

OTHER

lead

Evdokia Anagnostou

INDIV

NCT00490802 - Intranasal Oxytocin in the Treatment of Autism | Biotech Hunter | Biotech Hunter